Use of low-dose erythropoietin for the treatment of acute or chronic kidney failure and for the treatment of wounds

Details for Australian Patent Application No. 2005205917 (hide)

International Classifications

Event Publications

10 August 2006 PCT application entered the National Phase

PCT publication WO2005/070450 Priority application(s): WO2005/070450

18 November 2010 Application Accepted

Published as AU-B-2005205917

9 December 2010 Application for Amendment

The nature of the amendment is: Amend the invention title to read Use of low-dose erythropoietin for stimulation of endothelial progenitor cells, for organ regeneration and for slowing the progression of end-organ damage . Address for service in Australia - Phillips Ormonde Fitzpatrick 367 Collins Street Melbourne VIC 3000

31 March 2011 Amendment Made

31 March 2011 Standard Patent Sealed

16 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.